{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:09:24Z","timestamp":1789578564252,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2003,9,1]]},"DOI":"10.1038\/sj.bmt.1704198","type":"journal-article","created":{"date-parts":[[2003,9,3]],"date-time":"2003-09-03T10:50:12Z","timestamp":1062586212000},"page":"543-548","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":182,"title":["Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: A Pediatric Blood and Marrow Transplant Consortium study"],"prefix":"10.1038","volume":"32","author":[{"given":"N","family":"Bunin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Aplenc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Kamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Cnaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Simms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,9,3]]},"reference":[{"key":"BF1704198_CR1","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1182\/blood.V83.9.2723.2723","volume":"83","author":"O Ringden","year":"1994","unstructured":"Ringden O, Ruutu T, Remberger M et al. A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplantation recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group. Blood 1994; 83: 2723\u20132730.","journal-title":"Blood"},{"key":"BF1704198_CR2","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1182\/blood.V84.6.2036.2036","volume":"84","author":"R Clift","year":"1994","unstructured":"Clift R, Buckner C, Thomas E et al. Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 1994; 84: 2036\u20132043.","journal-title":"Blood"},{"key":"BF1704198_CR3","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1200\/JCO.1994.12.6.1217","volume":"12","author":"G Michel","year":"1994","unstructured":"Michel G, Gluckman E, Esperou-Bourdeau H et al. Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation \u2013 a report from the Societe Francaise de Greffe de Moelle. J Clin Oncol 1994; 12: 1217\u20131222.","journal-title":"J Clin Oncol"},{"key":"BF1704198_CR4","first-page":"313","volume":"9","author":"W Emminger","year":"1992","unstructured":"Emminger W, Emminger-Schmidmeier W, Haas OA et al. Treatment of infant leukemia with busulfan, cyclophosphamide +\/\u2212 etoposide and bone marrow transplantation. Bone Marrow Transplant 1992; 9: 313\u2013318.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704198_CR5","unstructured":"Lenarsky C, Weinberg K, Kohn D et al. Bone marrow transplantation for children with acute lymphoblastic leukemia without total body irradiation. Blood 1994; 84 abst: 549a."},{"key":"BF1704198_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/sj.bmt.1701276","volume":"22","author":"T Matsuyama","year":"1998","unstructured":"Matsuyama T, Kojima S, Kato K . Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen. Bone Marrow Transplant 1998; 22: 21\u201326.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704198_CR7","first-page":"521","volume":"16","author":"A von Bueltzingsloewen","year":"1995","unstructured":"von Bueltzingsloewen A, Esperou-Bourdeau H, Souillet G et al. Allogeneic bone marrow transplantation following a busulfan-based conditioning regimen in young children with acute lymphoblastic leukemia: a Cooperative Study of the Societe Francaise de Greffe de Moelle. Bone Marrow Transplant 1995; 16: 521\u2013527.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704198_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1146\/annurev.me.35.020184.000303","volume":"3","author":"H Deeg","year":"1984","unstructured":"Deeg H, Storb R . Graft-versus-host disease: pathophysiological and clinical aspects. Ann Rev Med 1984; 3: 11\u201324.","journal-title":"Ann Rev Med"},{"key":"BF1704198_CR9","unstructured":"Katz MH . Multivariable Analysis: A Practical Guide for Clinicians. University of Cambridge, Cambridge, 1999 to 1992."},{"key":"BF1704198_CR10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1200\/JCO.2001.19.2.464","volume":"19","author":"S Bhatia","year":"2001","unstructured":"Bhatia S, Louie AD, Bhatia R et al. Solid cancers after bone marrow transplantation. J Clin Oncol 2001; 19: 464\u2013471.","journal-title":"J Clin Oncol"},{"key":"BF1704198_CR11","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1056\/NEJM199703273361301","volume":"336","author":"RE Curtis","year":"1997","unstructured":"Curtis RE, Rowlings PA, Deeg HJ et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997; 336: 897\u2013904.","journal-title":"N Engl J Med"},{"key":"BF1704198_CR12","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1200\/JCO.2000.18.5.1004","volume":"18","author":"S Phipps","year":"2000","unstructured":"Phipps S, Dunavant M, Srivastava DK et al. Cognitive and academic functioning in survivors of pediatric bone marrow transplantation. J Clin Oncol 2000; 18: 1004\u20131011.","journal-title":"J Clin Oncol"},{"key":"BF1704198_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/00043426-200202000-00011","volume":"24","author":"S Sims","year":"2002","unstructured":"Sims S, Kazak A, Golomb V et al. Cognitive, behavioral, and social outcome in survivors of childhood stem cell transplantation. J Pediatr Hematol\/Oncol 2002; 24: 115\u2013119.","journal-title":"J Pediatr Hematol\/Oncol"},{"key":"BF1704198_CR14","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1182\/blood.V86.2.819.bloodjournal862819","volume":"86","author":"Z Huma","year":"1995","unstructured":"Huma Z, Boulad F, Black P et al. Growth in children after bone marrow transplantation for acute leukemia. Blood 1995; 86: 819\u2013824.","journal-title":"Blood"},{"key":"BF1704198_CR15","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1182\/blood.V86.2.825.bloodjournal862825","volume":"86","author":"G Giorgiani","year":"1995","unstructured":"Giorgiani G, Bozzola M, Locatelli F et al. Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. Blood 1995; 86: 825\u2013831.","journal-title":"Blood"},{"key":"BF1704198_CR16","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/sj.bmt.1702384","volume":"25","author":"Z Afify","year":"2000","unstructured":"Afify Z, Shaw PJ, Clavano-Harding A, Cowell CT . Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan\/cyclophosphamide. Bone Marrow Transplant 2000; 25: 1087\u20131092.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704198_CR17","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/00043426-199611000-00005","volume":"18","author":"S Shankar","year":"1996","unstructured":"Shankar S, Bunin N . Growth in children undergoing bone marrow transplantation using busulfan and cyclophosphamide. J Pediatr Hematol\/Oncol 1996; 18: 362\u2013366.","journal-title":"J Pediatr Hematol\/Oncol"},{"key":"BF1704198_CR18","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1200\/JCO.1997.15.6.2238","volume":"15","author":"G Michel","year":"1997","unstructured":"Michel G, Socie G, Gebhard F et al. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: The impact of conditioning regimen without total-body irradiation\u2013a report from the Societe Francaise de Greffe de Moelle. J Clin Oncol 1997; 15: 2238\u20132246.","journal-title":"J Clin Oncol"},{"key":"BF1704198_CR19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1200\/JCO.1992.10.2.237","volume":"10","author":"EA Copelan","year":"1992","unstructured":"Copelan EA, Biggs JC, Avalos BR et al. Radiation-free preparation for allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia. J Clin Oncol 1992; 10: 237\u2013242.","journal-title":"J Clin Oncol"},{"key":"BF1704198_CR20","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1182\/blood.V85.5.1391.bloodjournal8551391","volume":"85","author":"RA Brown","year":"1995","unstructured":"Brown RA, Wolf SN, Fay JW et al. High dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant Group. Blood 1995; 85: 1391\u20131395.","journal-title":"Blood"},{"key":"BF1704198_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3109\/08880019609033371","volume":"13","author":"M Horstmann","year":"1996","unstructured":"Horstmann M, Kroschke G, Stockschlader M et al. Early toxicity of intensified conditioning with etoposide combined with total body irradiation\/cyclophosphamide or busulfan\/cyclophosphamide in children undergoing autologous or allogeneic bone marrow transplantation. Pediatr Hematol\/Oncol 1996; 13: 45\u201353.","journal-title":"Pediatr Hematol\/Oncol"},{"key":"BF1704198_CR22","first-page":"2671","volume":"3","author":"AR Zander","year":"1997","unstructured":"Zander AR, Berger C, Kroger N et al. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission. Clin Cancer Res 1997; 3: 2671\u20132675.","journal-title":"Clin Cancer Res"},{"key":"BF1704198_CR23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/1096-911X(20001001)35:4<403::AID-MPO2>3.0.CO;2-M","volume":"35","author":"ES Sandler","year":"2000","unstructured":"Sandler ES, Hagg R, Coppes MJ et al. Hematopoietic Stem Cell Transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide, and etoposide for children with acute myelogenous leukemia AML): a phase I study of the Pediatric Blood and Marrow Transplant Consortium. Med Pediatr Oncol 2000; 35: 403\u2013409.","journal-title":"Med Pediatr Oncol"},{"key":"BF1704198_CR24","first-page":"361","volume":"15","author":"P Crilley","year":"1995","unstructured":"Crilley P, Topolsky D, Styler MJ et al. Extramedullary toxicity of a conditioning regimen containing busulphan, cyclophosphamide and etoposide in 84 patients undergoing autologous and allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 15: 361\u2013365.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704198_CR25","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/sj.bmt.1702433","volume":"25","author":"EA Copelan","year":"2000","unstructured":"Copelan EA, Penza SL, Pohlman B et al. Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma. Bone Marrow Transplant 2000; 25: 1243\u20131248.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704198_CR26","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1200\/JCO.2000.18.2.340","volume":"18","author":"SM Davies","year":"2000","unstructured":"Davies SM, Ramsay NKC, Klein JP et al. Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. J Clin Oncol 2000; 18: 340\u2013347.","journal-title":"J Clin Oncol"},{"key":"BF1704198_CR27","first-page":"75","volume":"17","author":"C Rozman","year":"1996","unstructured":"Rozman C, Carreras E, Qian C et al. Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplantation for leukemia. Bone Marrow Transplant 1996; 17: 75\u201380.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704198_CR28","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood.V93.7.2196","volume":"93","author":"O Ringden","year":"1999","unstructured":"Ringden O, Remberger M, Ruutu T et al. Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long term results of a randomized trial in allogeneic marrow recipients with leukemia. Blood 1999; 93: 2196\u20132201.","journal-title":"Blood"},{"key":"BF1704198_CR29","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1046\/j.1365-2141.1996.d01-1681.x","volume":"93","author":"O Ringden","year":"1996","unstructured":"Ringden O, Labopin M, Tura S et al. A comparison of busulfan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukemia. Br J Haematol 1996; 93: 637\u2013645.","journal-title":"Br J Haematol"},{"key":"BF1704198_CR30","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1182\/blood.V98.13.3569","volume":"98","author":"G Socie","year":"2001","unstructured":"Socie G, Clift RA, Blaise D et al. Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies. Blood 2001; 98: 3569\u20133574.","journal-title":"Blood"},{"key":"BF1704198_CR31","first-page":"583","volume":"13","author":"J Mehta","year":"1994","unstructured":"Mehta J, Powles RL, Mitchell P et al. Graft failure after bone marrow transplantation from unrelated donors using busulfphan and cyclophosphamide conditioning. Bone Marrow Transplant 1994; 13: 583\u2013587.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704198_CR32","first-page":"31","volume":"16","author":"JT Slattery","year":"1995","unstructured":"Slattery JT, Sanders JE, Buckner CD et al. Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics. Bone Marrow Transplant 1995; 16: 31\u201342.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704198_CR33","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood.V75.8.1723.1723","volume":"75","author":"L Grochow","year":"1990","unstructured":"Grochow L, Krivit W, Blazar B . Busulfan disposition in children. Blood 1990; 75: 1723\u20131727.","journal-title":"Blood"},{"key":"BF1704198_CR34","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/BF00257448","volume":"24","author":"G Vassal","year":"1989","unstructured":"Vassal G, Gouyette A, Hartmann O et al. Pharmacokinetics of high-dose busulfan in children. Cancer Chemother Pharmacol 1989; 24: 386\u2013390.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF1704198_CR35","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1182\/blood.V84.7.2144.2144","volume":"84","author":"M Hassan","year":"1994","unstructured":"Hassan M, Ljungman P, Bolme P et al. Busulfan bioavailability. Blood 1994; 84: 2144\u20132150.","journal-title":"Blood"},{"key":"BF1704198_CR36","first-page":"193","volume":"1","author":"PJ Shaw","year":"1986","unstructured":"Shaw PJ, Hugh-Jones K, Hobbs JR et al. Busulphan and cyclophosphamide cause little early toxicity during displacement bone marrow transplantation in fifty children. Bone Marrow Transplant 1986; 1: 193.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704198_CR37","first-page":"759","volume":"14","author":"U Schuler","year":"1994","unstructured":"Schuler U, Schroer S, Kuhnle A et al. Busulfan pharmacokinetics in bone marrow transplant patients: is drug monitoring warranted? Bone Marrow Transplant 1994; 14: 759\u2013765.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704198_CR38","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/sj.bmt.1702590","volume":"26","author":"K Baker","year":"2000","unstructured":"Baker K, Bostrom B, DeFor T et al. Busulfan pharmacokinetics do not predict relapse in acute myeloid leukemia. Bone Marrow Transplant 2000; 26: 607\u2013614.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704198","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704198.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704198.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:29:40Z","timestamp":1648078180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9,1]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,9,1]]}},"alternative-id":["BF1704198"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704198","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9,1]]},"assertion":[{"value":"7 November 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}